• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多聚 ADP-核糖触发染色质重塑致癌基因的自动抑制解除。

A Poly-ADP-Ribose Trigger Releases the Auto-Inhibition of a Chromatin Remodeling Oncogene.

机构信息

Biomedical Center Munich, Faculty of Medicine, Ludwig-Maximilians-Universität München, Großhaderner Street 9, 82152 Planegg-Martinsried, Germany.

Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark.

出版信息

Mol Cell. 2017 Dec 7;68(5):860-871.e7. doi: 10.1016/j.molcel.2017.11.019.

DOI:10.1016/j.molcel.2017.11.019
PMID:29220653
Abstract

DNA damage triggers chromatin remodeling by mechanisms that are poorly understood. The oncogene and chromatin remodeler ALC1/CHD1L massively decompacts chromatin in vivo yet is inactive prior to DNA-damage-mediated PARP1 induction. We show that the interaction of the ALC1 macrodomain with the ATPase module mediates auto-inhibition. PARP1 activation suppresses this inhibitory interaction. Crucially, release from auto-inhibition requires a poly-ADP-ribose (PAR) binding macrodomain. We identify tri-ADP-ribose as a potent PAR-mimic and synthetic allosteric effector that abrogates ATPase-macrodomain interactions, promotes an ungated conformation, and activates the remodeler's ATPase. ALC1 fragments lacking the regulatory macrodomain relax chromatin in vivo without requiring PARP1 activation. Further, the ATPase restricts the macrodomain's interaction with PARP1 under non-DNA damage conditions. Somatic cancer mutants disrupt ALC1's auto-inhibition and activate chromatin remodeling. Our data show that the NAD-metabolite and nucleic acid PAR triggers ALC1 to drive chromatin relaxation. Modular allostery in this oncogene tightly controls its robust, DNA-damage-dependent activation.

摘要

DNA 损伤通过机制触发染色质重塑,这些机制尚未得到很好的理解。致癌基因和染色质重塑因子 ALC1/CHD1L 在体内大量解压缩染色质,但在 DNA 损伤介导的 PARP1 诱导之前处于非活性状态。我们表明,ALC1 宏域与 ATP 酶模块的相互作用介导自动抑制。PARP1 激活抑制这种抑制性相互作用。至关重要的是,自动抑制的释放需要一个多聚 ADP-核糖(PAR)结合宏域。我们鉴定出三 ADP-核糖是一种有效的 PAR 模拟物和合成变构效应物,可破坏 ATP 酶-宏域相互作用,促进无门构象,并激活重塑因子的 ATP 酶。缺乏调节宏域的 ALC1 片段在体内松弛染色质而无需 PARP1 激活。此外,ATP 酶在非 DNA 损伤条件下限制了宏域与 PARP1 的相互作用。体细胞癌症突变破坏了 ALC1 的自动抑制并激活了染色质重塑。我们的数据表明,NAD 代谢物和核酸 PAR 触发 ALC1 驱动染色质松弛。这种致癌基因中的模块化变构作用严格控制其强大的、依赖于 DNA 损伤的激活。

相似文献

1
A Poly-ADP-Ribose Trigger Releases the Auto-Inhibition of a Chromatin Remodeling Oncogene.多聚 ADP-核糖触发染色质重塑致癌基因的自动抑制解除。
Mol Cell. 2017 Dec 7;68(5):860-871.e7. doi: 10.1016/j.molcel.2017.11.019.
2
Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1.致癌染色质重塑因子ALC1自身抑制作用的机制洞察
Mol Cell. 2017 Dec 7;68(5):847-859.e7. doi: 10.1016/j.molcel.2017.10.017.
3
Activation of the SNF2 family ATPase ALC1 by poly(ADP-ribose) in a stable ALC1·PARP1·nucleosome intermediate.稳定的 ALC1·PARP1·核小体中间物中多聚(ADP-核糖)对 SNF2 家族 ATP 酶 ALC1 的激活作用。
J Biol Chem. 2012 Dec 21;287(52):43527-32. doi: 10.1074/jbc.M112.401141. Epub 2012 Nov 6.
4
ALC1/CHD1L, a chromatin-remodeling enzyme, is required for efficient base excision repair.ALC1/CHD1L,一种染色质重塑酶,对于有效的碱基切除修复是必需的。
PLoS One. 2017 Nov 17;12(11):e0188320. doi: 10.1371/journal.pone.0188320. eCollection 2017.
5
Multiple roles for PARP1 in ALC1-dependent nucleosome remodeling.PARP1 在 ALC1 依赖性核小体重塑中的多种作用。
Proc Natl Acad Sci U S A. 2021 Sep 7;118(36). doi: 10.1073/pnas.2107277118.
6
Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1.染色质重塑酶ALC1对DNA修复的聚(ADP-核糖)依赖性调控。
Science. 2009 Sep 4;325(5945):1240-3. doi: 10.1126/science.1177321. Epub 2009 Aug 6.
7
Structure and dynamics of the chromatin remodeler ALC1 bound to a PARylated nucleosome.ALC1 与 PAR 化核小体结合的染色质重塑复合物的结构与动态。
Elife. 2021 Sep 6;10:e71420. doi: 10.7554/eLife.71420.
8
The poly(ADP-ribose)-dependent chromatin remodeler Alc1 induces local chromatin relaxation upon DNA damage.聚(ADP-核糖)依赖性染色质重塑因子Alc1在DNA损伤时诱导局部染色质松弛。
Mol Biol Cell. 2016 Dec 1;27(24):3791-3799. doi: 10.1091/mbc.E16-05-0269. Epub 2016 Oct 12.
9
The Oncogenic Helicase ALC1 Regulates PARP Inhibitor Potency by Trapping PARP2 at DNA Breaks.致癌解旋酶 ALC1 通过在 DNA 断裂处捕获 PARP2 来调节 PARP 抑制剂的效力。
Mol Cell. 2020 Dec 3;80(5):862-875.e6. doi: 10.1016/j.molcel.2020.10.009.
10
Chromatin remodeler ALC1 prevents replication-fork collapse by slowing fork progression.染色质重塑因子ALC1通过减缓复制叉推进来防止复制叉坍塌。
PLoS One. 2018 Feb 6;13(2):e0192421. doi: 10.1371/journal.pone.0192421. eCollection 2018.

引用本文的文献

1
Single nucleosome imaging reveals principles of transient multiscale chromatin reorganization triggered by histone ADP-ribosylation at DNA lesions.单核小体成像揭示了DNA损伤处组蛋白ADP核糖基化引发的瞬时多尺度染色质重组原理。
Nat Commun. 2025 Jul 19;16(1):6652. doi: 10.1038/s41467-025-61834-7.
2
Autoinhibition imposed by a large conformational switch of INO80 regulates nucleosome positioning.INO80的一个大型构象转换所施加的自抑制作用调节核小体定位。
Science. 2025 Jul 17;389(6757):eadr3831. doi: 10.1126/science.adr3831.
3
CHD1L in cancer and beyond: structure, oncogenic functions, and therapeutic potential.
CHD1L在癌症及其他领域:结构、致癌功能及治疗潜力
J Exp Clin Cancer Res. 2025 May 30;44(1):167. doi: 10.1186/s13046-025-03428-1.
4
Histone modifications and metabolic reprogramming in tumor-associated macrophages: a potential target of tumor immunotherapy.肿瘤相关巨噬细胞中的组蛋白修饰与代谢重编程:肿瘤免疫治疗的潜在靶点
Front Immunol. 2025 May 1;16:1521550. doi: 10.3389/fimmu.2025.1521550. eCollection 2025.
5
VRK1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma mediated by SNAI1 via phosphorylating CHD1L.VRK1通过磷酸化CHD1L促进由SNAI1介导的肝细胞癌上皮-间质转化。
Cell Death Dis. 2025 Apr 15;16(1):302. doi: 10.1038/s41419-025-07641-w.
6
Nucleolytic processing of abasic sites underlies PARP inhibitor hypersensitivity in ALC1-deficient BRCA mutant cancer cells.碱基切除修复缺陷的 BRCA 突变型癌细胞中,无碱基位点的核酸内切酶加工是 PARP 抑制剂超敏反应的基础。
Nat Commun. 2024 Jul 27;15(1):6343. doi: 10.1038/s41467-024-50673-7.
7
Histone ADP-ribosylation promotes resistance to PARP inhibitors by facilitating PARP1 release from DNA lesions.组蛋白 ADP-ribosylation 通过促进 PARP1 从 DNA 损伤中释放,从而促进对 PARP 抑制剂的耐药性。
Proc Natl Acad Sci U S A. 2024 Jun 18;121(25):e2322689121. doi: 10.1073/pnas.2322689121. Epub 2024 Jun 12.
8
Cooperative nucleic acid binding by Poly ADP-ribose polymerase 1.聚 ADP-核糖聚合酶 1 的协同核酸结合。
Sci Rep. 2024 Mar 29;14(1):7530. doi: 10.1038/s41598-024-58076-w.
9
Asymmetric nucleosome PARylation at DNA breaks mediates directional nucleosome sliding by ALC1.DNA 断裂处非对称核小体 PAR 化介由 ALC1 介导定向核小体滑动。
Nat Commun. 2024 Feb 2;15(1):1000. doi: 10.1038/s41467-024-45237-8.
10
The recruitment of ACF1 and SMARCA5 to DNA lesions relies on ADP-ribosylation dependent chromatin unfolding.ACF1 和 SMARCA5 被招募至 DNA 损伤部位依赖于 ADP-ribosylation 依赖的染色质展开。
Mol Biol Cell. 2024 Mar 1;35(3):br7. doi: 10.1091/mbc.E23-07-0281. Epub 2024 Jan 3.